Following leadership changes at the national level from the Pharmacy Guild and PSA, the SHPA has recommitted to its strategic partnerships with the groups
The statement follows the announcement last week that Guild national executive director David Quilty would retire, after six years in the job; and Graham Catt’s resignation as CEO of the Pharmaceutical Society of Australia, after less than a year in the role.
SHPA Chief Executive Kristin Michaels acknowledged the leadership and contributions made by Mr Quilty and Mr Catt.
“SHPA has enjoyed working with Mr Catt and Mr Quilty across a range of projects and, on behalf of our members, we will continue to closely cooperate with PSA and the Guild to strengthen Australian pharmacy, an essential pillar of the Australian health system,” Ms Michaels said.
She said SHPA also looks forward to advancing Australian pharmacy collaboratively with other key stakeholders, including medical and nursing stakeholders, consumers and federal and state governments and agencies.
“Harnessing the expertise of our members, SHPA is committed to working across the spectrum to address Australia’s significant healthcare challenges, in line with our vision of advancing pharmacy and advancing patient care.
“With the appointment of Peter Fowler as President in November and release of our Strategic Plan 2019-23 last month, SHPA is focused and ready to strengthen the impact of the profession and advance the impact of individual pharmacists and technicians, both within and beyond the hospital setting.”